Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 1
1999 1
2002 2
2003 5
2004 3
2011 1
2014 1
2015 2
2020 1
2021 1
2022 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Results by year

Citations

5 articles found by citation matching

Search results

Filters applied: . Clear all
Page 1
Effect of dialysis dose and membrane flux on hemoglobin cycling in hemodialysis patients.
He L, Fu M, Chen X, Liu H, Chen X, Peng X, Liu F, Peng Y. He L, et al. Hemodial Int. 2015 Apr;19(2):263-9. doi: 10.1111/hdi.12215. Epub 2014 Sep 12. Hemodial Int. 2015. PMID: 25215434 Clinical Trial.
Many studies found that hemoglobin (Hb) fluctuation was closely related to the prognosis of the maintenance hemodialysis patients. We investigated the association of factors relating dialysis dose and dialyzer membrane with Hb levels. ... …
Many studies found that hemoglobin (Hb) fluctuation was closely related to the prognosis of the maintenance hemodialysis patie …
Effect of dialysis dose and membrane flux in maintenance hemodialysis.
Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R; Hemodialysis (HEMO) Study Group. Eknoyan G, et al. N Engl J Med. 2002 Dec 19;347(25):2010-9. doi: 10.1056/NEJMoa021583. N Engl J Med. 2002. PMID: 12490682 Free article. Clinical Trial.
BACKGROUND: The effects of the dose of dialysis and the level of flux of the dialyzer membrane on mortality and morbidity among patients undergoing maintenance hemodialysis are uncertain. ...CONCLUSIONS: Patients undergoing …
BACKGROUND: The effects of the dose of dialysis and the level of flux of the dialyzer membrane on …
The effect of dialysis dose and membrane flux on nutritional parameters in hemodialysis patients: results of the HEMO Study.
Rocco MV, Dwyer JT, Larive B, Greene T, Cockram DB, Chumlea WC, Kusek JW, Leung J, Burrowes JD, McLeroy SL, Poole D, Uhlin L; HEMO Study Group. Rocco MV, et al. Kidney Int. 2004 Jun;65(6):2321-34. doi: 10.1111/j.1523-1755.2004.00647.x. Kidney Int. 2004. PMID: 15149346 Free article. Clinical Trial.
BACKGROUND: The effect of standard or high dialysis dose and low or high dialysis flux on nutritional status was ascertained in 1846 maintenance hemodialysis patients enrolled in the HEMO Study. ...For years 1, 2, and 3, the mean + …
BACKGROUND: The effect of standard or high dialysis dose and low or high dialysis flux on nutritional sta …
Effects of hemodialysis dose and membrane flux on health-related quality of life in the HEMO Study.
Unruh M, Benz R, Greene T, Yan G, Beddhu S, DeVita M, Dwyer JT, Kimmel PL, Kusek JW, Martin A, Rehm-McGillicuddy J, Teehan BP, Meyer KB; HEMO Study Group. Unruh M, et al. Kidney Int. 2004 Jul;66(1):355-66. doi: 10.1111/j.1523-1755.2004.00738.x. Kidney Int. 2004. PMID: 15200444 Free article. Clinical Trial.
BACKGROUND: It has been widely supposed that high dose and high flux hemodialysis would affect the quality as well as the length of life of patients treated by maintenance hemodialysis. ...CONCLUSION: The HEMO Study results demonstrate the marke …
BACKGROUND: It has been widely supposed that high dose and high flux hemodialysis would affect the quality as well as t …
Pharmacokinetics of Certoparin During In Vitro and In Vivo Dialysis.
Krieter DH, Fink S, Dorsch O, Harenberg J, Melzer N, Wanner C, Lemke HD. Krieter DH, et al. Artif Organs. 2015 Nov;39(11):951-9. doi: 10.1111/aor.12475. Epub 2015 Apr 20. Artif Organs. 2015. PMID: 25900127 Clinical Trial.
The efficacy and safety of certoparin in the prophylaxis of clotting during hemodialysis have recently been proven. Different to other low-molecular weight heparins (LMWHs), certoparin does not accumulate in maintenance dialysis patients for unknown reasons. …
The efficacy and safety of certoparin in the prophylaxis of clotting during hemodialysis have recently been proven. Different to othe …
Predialysis serum phosphate and intradialytic hypotension.
Ravi KS, Reeves PB, Correa S, Neves JS, Waikar SS, Mothi SS, Mc Causland FR. Ravi KS, et al. Hemodial Int. 2022 Jan;26(1):38-47. doi: 10.1111/hdi.12971. Epub 2021 Jul 8. Hemodial Int. 2022. PMID: 34236130 Clinical Trial.
INTRODUCTION: Intradialytic hypotension (IDH) is a common complication of hemodialysis (HD) and is associated with excess morbidity and mortality. Higher serum phosphate is associated with adverse cardiovascular outcomes in maintenance HD patients; however, its asso …
INTRODUCTION: Intradialytic hypotension (IDH) is a common complication of hemodialysis (HD) and is associated with excess morbidity a …
The HEMO study - where do we go from here?
Himmelfarb J. Himmelfarb J. Curr Opin Nephrol Hypertens. 2003 Nov;12(6):587-91. doi: 10.1097/00041552-200311000-00003. Curr Opin Nephrol Hypertens. 2003. PMID: 14564194 Review.
PURPOSE OF REVIEW: The HEMO study is a randomized clinical trial using a 2x2 factorial design to assign patients to a standard or high dose of dialysis and to a low flux or a high flux dialyzer. This study is the largest, most comprehensive, ran …
PURPOSE OF REVIEW: The HEMO study is a randomized clinical trial using a 2x2 factorial design to assign patients to a standard or high do
18 results